摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-cis-3-ethyl-1,2,3,4,6,11-hexahydro-1,3,5,12-tetrahydroxynaphthacene-6,11-quinone | 81844-85-1

中文名称
——
中文别名
——
英文名称
(S)-cis-3-ethyl-1,2,3,4,6,11-hexahydro-1,3,5,12-tetrahydroxynaphthacene-6,11-quinone
英文别名
(7S,9S)-9-ethyl-6,7,9,11-tetrahydroxy-8,10-dihydro-7H-tetracene-5,12-dione
(S)-cis-3-ethyl-1,2,3,4,6,11-hexahydro-1,3,5,12-tetrahydroxynaphthacene-6,11-quinone化学式
CAS
81844-85-1
化学式
C20H18O6
mdl
——
分子量
354.359
InChiKey
LLNJQZPRRRZFMP-YUNKPMOVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    26
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    115
  • 氢给体数:
    4
  • 氢受体数:
    6

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • ADAMS, NIGEL;BLAKE, COLIN;BROADHURST, MICHAEL J.;BUSHNELL, DAVID J.;HASSA+, J. MED. CHEM., 33,(1990) N, C. 2375-2379
    作者:ADAMS, NIGEL、BLAKE, COLIN、BROADHURST, MICHAEL J.、BUSHNELL, DAVID J.、HASSA+
    DOI:——
    日期:——
  • 3,5,12-Trihydroxy-6,11-dioxonaphthacene
    申请人:F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft
    公开号:EP0106996B1
    公开(公告)日:1986-12-30
  • US4591636A
    申请人:——
    公开号:US4591636A
    公开(公告)日:1986-05-27
  • Synthesis and antitumor activity of novel 4-demethoxyanthracyclines
    作者:Nigel Adams、Colin Blake、Michael J. Broadhurst、David J. Bushnell、Cedric H. Hassall、Hans R. Hartmann、Elizabeth Keech、Alan R. Stratton、Gareth J. Thomas
    DOI:10.1021/jm00171a010
    日期:1990.9
    A versatile and efficient synthetic route to 4-demethoxyanthracyclinones has been utilized in the preparation of a number of aglycons having 9-alkyl, 9-(hydroxylalkyl), or 9-carbamoyl substituents. Silver trifluoromethanesulfonate catalyzed coupling of these aglycons with various daunosamine derivatives has yielded a series of novel anthracyclines which have been evaluated as antitumor agents. 9-Alkylanthracyclines 22, 23, 33, and 34 have higher efficacy vs L-1210 leukemia than the parent 4-demethoxydaunorubicin (21), or the natural anthracyclines daunorubicin (1) and doxorubicin (2). 9-(Hydroxyalkyl) derivatives have in most cases high efficacy but are slightly less potent than 21. 9-Methyl analogue 22 has higher efficacy vs P388 leukemia than other anthracyclines tested, while 9-(hydroxymethyl) derivative 37 retains similar efficacy to anthracyclines 1, 2, and 21 but is considerably more potent. The N-substituted 9-carbamoylanthracyclines are devoid of antitumor activity.
  • Total synthesis of some new 4-demethoxyanthracyclinones
    作者:Michael J. Broadhurst、Cedric H. Hassall、Gareth J. Thomas
    DOI:10.1016/s0040-4020(01)91526-1
    日期:1984.1
查看更多